{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:35:05Z","timestamp":1792636505207,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.virusres.2023.199175","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T18:31:30Z","timestamp":1689964290000},"page":"199175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers"],"prefix":"10.1016","volume":"334","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9788-425X","authenticated-orcid":false,"given":"Manon\u2009L.M.","family":"Prins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2530-6260","authenticated-orcid":false,"given":"Jutte\u2009J.C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3600-9782","authenticated-orcid":false,"given":"Leo\u2009G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1397-0992","authenticated-orcid":false,"given":"Anna\u2009H.E.","family":"Roukens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10287","key":"10.1016\/j.virusres.2023.199175_bib0001","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.virusres.2023.199175_bib0002","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJMoa2110362","article-title":"Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings","volume":"385","author":"Thompson","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.virusres.2023.199175_bib0005","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.vaccine.2021.12.062","article-title":"Understanding COVID-19 vaccination willingness among youth: a survey study in the Netherlands","volume":"40","author":"Euser","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2023.199175_bib0007","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.puhe.2021.02.025","article-title":"Vaccine hesitancy in the era of COVID-19","volume":"194","author":"Troiano","year":"2021","journal-title":"Public Health"},{"issue":"8","key":"10.1016\/j.virusres.2023.199175_bib0008","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14760584.7.8.1201","article-title":"Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice","volume":"7","author":"Nicolas","year":"2008","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.virusres.2023.199175_bib0009","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/jidsymp.2011.5","article-title":"The cutaneous vascular system in chronic skin inflammation","volume":"15","author":"Huggenberger","year":"2011","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"issue":"3","key":"10.1016\/j.virusres.2023.199175_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2471\/BLT.10.079426","article-title":"Intradermal delivery of vaccines: potential benefits and current challenges","volume":"89","author":"Hickling","year":"2011","journal-title":"Bull. World Health Organ."},{"issue":"12","key":"10.1016\/j.virusres.2023.199175_bib0011","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.7326\/M22-2089","article-title":"Safety and immunogenicity of intradermal fractional dose administration of the mRNA-1273 vaccine: a proof-of-concept study","volume":"175","author":"Roozen","year":"2022","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.virusres.2023.199175_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/nri1728","article-title":"Immunization without needles","volume":"5","author":"Mitragotri","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"16","key":"10.1016\/j.virusres.2023.199175_bib0013","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/polym13162815","article-title":"Review of microneedles: types, materials, processes, characterizations and applications","volume":"13","author":"Aldawood","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.virusres.2023.199175_bib0014","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mattod.2022.10.025","article-title":"Design principles of microneedles for drug delivery and sampling applications","volume":"63","author":"Le","year":"2023","journal-title":"Mater. Today"},{"issue":"3","key":"10.1016\/j.virusres.2023.199175_bib0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2010.09.018","article-title":"Advances in transcutaneous vaccine delivery: do all ways lead to Rome?","volume":"148","author":"Bal","year":"2010","journal-title":"J. Control Release"},{"issue":"2","key":"10.1016\/j.virusres.2023.199175_bib0016","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2012.01.042","article-title":"Microneedle technologies for (trans)dermal drug and vaccine delivery","volume":"161","author":"van der Maaden","year":"2012","journal-title":"J. Control Release"},{"issue":"4","key":"10.1016\/j.virusres.2023.199175_bib0017","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13346-015-0238-y","article-title":"Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays","volume":"5","author":"van der Maaden","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"issue":"4","key":"10.1016\/j.virusres.2023.199175_bib0018","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1208\/s12249-022-02250-8","article-title":"Microneedle-based vaccine delivery: review of an emerging technology","volume":"23","author":"Mansoor","year":"2022","journal-title":"AAPS PharmSci.Tech."},{"issue":"7","key":"10.1016\/j.virusres.2023.199175_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00388-21","article-title":"Clinical evaluation of the abbott alinity SARS-CoV-2 spike-specific quantitative IgG and IgM assays among infected, recovered, and vaccinated groups","volume":"59","author":"Narasimhan","year":"2021","journal-title":"J. Clin. Microbiol."},{"issue":"10095","key":"10.1016\/j.virusres.2023.199175_bib0022","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(17)30575-5","article-title":"The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial","volume":"390","author":"Rouphael","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2023.199175_bib0021","series-title":"SARS-CoV-2 Starter Set Blood Collection Tubes Instructions for Use (Handbook)","first-page":"11","author":"Qiagen","year":"2020"},{"key":"10.1016\/j.virusres.2023.199175_bib0020","series-title":"Instructions for Use (Handbook)","first-page":"13","year":"2021"},{"key":"10.1016\/j.virusres.2023.199175_bib0003","unstructured":"Our World in Data. Coronavirus (COVID-19) vaccinations. https:\/\/ourworldindata.org\/covid-vaccinations (accessed 20 July 2023)."},{"key":"10.1016\/j.virusres.2023.199175_bib0006","unstructured":"WHO. Ten threats to global health in 2019.https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019 (accessed 16 June 2022)."},{"key":"10.1016\/j.virusres.2023.199175_bib0004","unstructured":"WHO. Vaccine equity.https:\/\/www.who.int\/campaigns\/vaccine-equity (accessed 9 January 2023)."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170223001375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170223001375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:22:41Z","timestamp":1759155761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170223001375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":22,"alternative-id":["S0168170223001375"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2023.199175","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2023.199175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199175"}}